The Latest Breaking News from Steve Reitmeister

The biotechnology sector has experienced extraordinary expansion, largely due to technological advancements that continue to position the industry as a pioneering influencer in crucial areas of healthcare, agriculture, and environmental stability. Given this backdrop, quality biotech stocks Gilead Sciences (GILD), Regeneron Pharmaceuticals (REGN), and United Therapeutics (UTHR) could be solid…

Despite macroeconomic uncertainties, the P&C insurance industry remained resilient and is poised for continued growth, driven by stable demand and rapid adoption of emerging technologies. Moreover, the sector benefits significantly from higher interest rates. So, let’s compare prominent insurance stocks Berkshire Hathaway (BRK.B) and Fairfax Financial (FRFH) to determine a…

The new bull market is hand as the S&P 500 (SPY) moves ever closer to the all time highs. However, that doesn’t mean we can fall asleep at the wheel as the health of the economy is always part of the stock investment equation. As such let’s review the Big…

The #1 problem for investors is underperforming the stock market (SPY). The #2 problem is how much time they spend (aka waste) to achieve these poor outcomes. The above problems explain why veteran investor Steve Reitmeister is now sharing insights on a proven method to beat the market in as…